September is blood cancer awareness month

Meet Itai Hayut, Co-founder and CEO of Scopio Labs, as he discusses our innovative full-field imaging technology and its impact on the medical field. Learn about the unique benefits of our solutions, recent advancements in peripheral blood smear and bone marrow analysis, and the future of hematology diagnostics powered by AI.

Dr. Katz presents the novel concept of “morphometry”, the groundbreaking ability to quantify morphological parameters at scale using Full-Field technology and AI. He will share the results from recent MDS and CAR-T cell therapy morphology research performed at TASMC, illustrating how accurate measurement of the morphological parameters could enhance diagnostic precision and yield new, morphology-based biomarkers.

Scopio enables ZLM to achieve fully digital remote workflows, accelerate diagnosis, and improve patient care.